Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Recruiting · NCT05961761 · Registry updated 2023-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, angiosarcoma, connective tissue neoplasm, histiocytoma, neoplasm, sarcoma, undifferentiated pleomorphic sarcoma, vascular cancer | Recruiting | Phase 2 | 2023-07-27 | NCT05961761 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aarhus University Hospital | 297 |
| Karolinska University Hospital | 181 |
| Niels Junker | 1 |
| Oslo University Hospital | 327 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aarhus University Hospital | Aarhus | Denmark | 95 |
| Herlev Gentofte Hospital | Herlev | Denmark | 4 |
| Karolinska University Hospital | Stockholm | Sweden | 87 |
| Oslo University Hospital | Oslo | Norway | 111 |